Viewing Study NCT00137969


Ignite Creation Date: 2025-12-24 @ 10:50 PM
Ignite Modification Date: 2026-03-27 @ 11:51 AM
Study NCT ID: NCT00137969
Status: COMPLETED
Last Update Posted: 2019-08-20
First Post: 2005-08-26
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus
Sponsor: Genentech, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lupus Erythematosus, Systemic View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Rituxan View
None SLE View
None Lupus View